Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacteria, Anaerobic | 2 | 2019 | 68 | 1.280 |
Why?
|
| Intestines | 6 | 2019 | 1923 | 1.130 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 3 | 2021 | 520 | 0.740 |
Why?
|
| Bacterial Infections | 2 | 2019 | 1389 | 0.710 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2021 | 236 | 0.650 |
Why?
|
| Tenericutes | 1 | 2017 | 2 | 0.620 |
Why?
|
| Caloric Restriction | 1 | 2019 | 302 | 0.590 |
Why?
|
| Microbiology | 1 | 2017 | 72 | 0.580 |
Why?
|
| Metagenome | 5 | 2017 | 417 | 0.510 |
Why?
|
| Growth and Development | 1 | 2014 | 51 | 0.500 |
Why?
|
| Probiotics | 4 | 2021 | 351 | 0.490 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2021 | 834 | 0.480 |
Why?
|
| Methylcellulose | 1 | 2012 | 37 | 0.450 |
Why?
|
| Phylogeny | 3 | 2017 | 2797 | 0.440 |
Why?
|
| Penicillins | 2 | 2017 | 378 | 0.440 |
Why?
|
| Anti-Bacterial Agents | 6 | 2018 | 7153 | 0.400 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 1060 | 0.370 |
Why?
|
| RNA, Ribosomal, 16S | 4 | 2018 | 947 | 0.340 |
Why?
|
| Dietary Fiber | 1 | 2012 | 760 | 0.330 |
Why?
|
| Obesity | 3 | 2014 | 12705 | 0.300 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 1617 | 0.300 |
Why?
|
| Sex Factors | 1 | 2019 | 10392 | 0.260 |
Why?
|
| Feces | 7 | 2021 | 1394 | 0.260 |
Why?
|
| Mice | 18 | 2021 | 81045 | 0.260 |
Why?
|
| Biomedical Research | 2 | 2019 | 3306 | 0.260 |
Why?
|
| Intestinal Mucosa | 3 | 2021 | 3038 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 13 | 2021 | 21821 | 0.220 |
Why?
|
| Helicobacter pylori | 2 | 2017 | 381 | 0.220 |
Why?
|
| Helicobacter Infections | 2 | 2017 | 385 | 0.220 |
Why?
|
| Animals | 23 | 2021 | 168561 | 0.200 |
Why?
|
| Stomach | 2 | 2017 | 697 | 0.200 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2021 | 18 | 0.200 |
Why?
|
| Bifidobacterium | 2 | 2018 | 100 | 0.190 |
Why?
|
| Multiple Sclerosis | 3 | 2019 | 3076 | 0.180 |
Why?
|
| Microglia | 2 | 2018 | 1261 | 0.180 |
Why?
|
| Nevada | 1 | 2019 | 22 | 0.180 |
Why?
|
| Prevotella | 1 | 2019 | 79 | 0.180 |
Why?
|
| Aquaporin 4 | 1 | 2020 | 153 | 0.180 |
Why?
|
| Mice, Inbred DBA | 1 | 2019 | 642 | 0.160 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 7988 | 0.160 |
Why?
|
| Apyrase | 1 | 2021 | 364 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 18006 | 0.160 |
Why?
|
| Societies, Scientific | 1 | 2019 | 220 | 0.160 |
Why?
|
| Receptors, Chemokine | 1 | 2021 | 669 | 0.160 |
Why?
|
| Bacteria | 5 | 2017 | 2102 | 0.160 |
Why?
|
| Brain | 3 | 2021 | 26343 | 0.150 |
Why?
|
| Tennessee | 1 | 2017 | 117 | 0.150 |
Why?
|
| Fusobacterium necrophorum | 1 | 2017 | 14 | 0.150 |
Why?
|
| Base Composition | 1 | 2017 | 293 | 0.150 |
Why?
|
| Neuromyelitis Optica | 1 | 2020 | 253 | 0.140 |
Why?
|
| Fusobacterium Infections | 1 | 2017 | 53 | 0.140 |
Why?
|
| Bacterial Typing Techniques | 1 | 2017 | 256 | 0.140 |
Why?
|
| Atrophy | 1 | 2021 | 1576 | 0.140 |
Why?
|
| Tylosin | 1 | 2015 | 3 | 0.140 |
Why?
|
| Protease Inhibitors | 1 | 2019 | 790 | 0.130 |
Why?
|
| DNA, Bacterial | 2 | 2017 | 1465 | 0.130 |
Why?
|
| Pharyngitis | 1 | 2017 | 215 | 0.130 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2021 | 2410 | 0.130 |
Why?
|
| Adenosine Triphosphate | 1 | 2021 | 2024 | 0.130 |
Why?
|
| Interferon Type I | 1 | 2018 | 542 | 0.120 |
Why?
|
| Somatosensory Cortex | 1 | 2018 | 527 | 0.120 |
Why?
|
| Pituitary-Adrenal System | 1 | 2018 | 553 | 0.120 |
Why?
|
| Body Weight | 3 | 2014 | 4664 | 0.120 |
Why?
|
| Amoxicillin | 1 | 2015 | 170 | 0.120 |
Why?
|
| Helminthiasis | 1 | 2014 | 66 | 0.120 |
Why?
|
| Colitis | 2 | 2021 | 1149 | 0.120 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2018 | 703 | 0.120 |
Why?
|
| Monocytes | 3 | 2018 | 2593 | 0.110 |
Why?
|
| Inflammation | 1 | 2013 | 10578 | 0.110 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 159 | 0.110 |
Why?
|
| Mouth | 1 | 2016 | 373 | 0.110 |
Why?
|
| Central Nervous System | 1 | 2020 | 1354 | 0.110 |
Why?
|
| Cell Death | 1 | 2018 | 1695 | 0.110 |
Why?
|
| Homeostasis | 2 | 2021 | 3335 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 2 | 2019 | 1477 | 0.110 |
Why?
|
| Polysaccharides | 1 | 2019 | 1051 | 0.110 |
Why?
|
| Prebiotics | 1 | 2012 | 44 | 0.110 |
Why?
|
| Gastric Mucosa | 1 | 2016 | 598 | 0.110 |
Why?
|
| Autoimmunity | 1 | 2020 | 1348 | 0.110 |
Why?
|
| Dendritic Cells | 2 | 2021 | 2723 | 0.110 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2014 | 455 | 0.110 |
Why?
|
| Myeloid Cells | 1 | 2016 | 804 | 0.100 |
Why?
|
| RNA, Bacterial | 1 | 2012 | 391 | 0.090 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 1780 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 12071 | 0.090 |
Why?
|
| Vagina | 1 | 2016 | 825 | 0.090 |
Why?
|
| Mycobacterium | 1 | 2012 | 249 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2021 | 2749 | 0.090 |
Why?
|
| Diet, Fat-Restricted | 1 | 2012 | 317 | 0.090 |
Why?
|
| Biodiversity | 1 | 2012 | 341 | 0.090 |
Why?
|
| Female | 20 | 2021 | 379592 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2017 | 1806 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 4801 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2019 | 2585 | 0.080 |
Why?
|
| Colon | 2 | 2017 | 1773 | 0.080 |
Why?
|
| Liver | 4 | 2019 | 7470 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 2513 | 0.080 |
Why?
|
| Disease Management | 1 | 2019 | 2450 | 0.080 |
Why?
|
| Cesarean Section | 1 | 2016 | 1363 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2017 | 3493 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2019 | 23387 | 0.070 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 3574 | 0.070 |
Why?
|
| Humans | 21 | 2021 | 742088 | 0.070 |
Why?
|
| Lactobacillus | 2 | 2018 | 189 | 0.070 |
Why?
|
| Metabolome | 1 | 2012 | 881 | 0.070 |
Why?
|
| Pregnancy | 4 | 2017 | 29087 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2016 | 4024 | 0.070 |
Why?
|
| Energy Metabolism | 2 | 2015 | 2896 | 0.070 |
Why?
|
| Gastric Bypass | 1 | 2013 | 812 | 0.060 |
Why?
|
| Male | 16 | 2021 | 349538 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 4933 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2019 | 3731 | 0.060 |
Why?
|
| Adiposity | 1 | 2012 | 1806 | 0.050 |
Why?
|
| Skin | 1 | 2016 | 4353 | 0.050 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 1969 | 0.050 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2012 | 1825 | 0.050 |
Why?
|
| Quality of Life | 1 | 2021 | 12730 | 0.040 |
Why?
|
| Lactase | 1 | 2019 | 69 | 0.040 |
Why?
|
| Diet | 2 | 2019 | 7923 | 0.040 |
Why?
|
| Neurons | 1 | 2018 | 9325 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2019 | 188 | 0.040 |
Why?
|
| Rotarod Performance Test | 1 | 2018 | 64 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11470 | 0.040 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2018 | 39 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2018 | 107 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2012 | 3843 | 0.040 |
Why?
|
| Plants | 1 | 2019 | 314 | 0.040 |
Why?
|
| Minocycline | 1 | 2018 | 163 | 0.040 |
Why?
|
| Lung | 1 | 2016 | 9826 | 0.040 |
Why?
|
| Adult | 6 | 2021 | 213712 | 0.040 |
Why?
|
| Chemokine CX3CL1 | 1 | 2016 | 58 | 0.040 |
Why?
|
| Methane | 1 | 2016 | 51 | 0.040 |
Why?
|
| Streptococcus | 1 | 2017 | 197 | 0.040 |
Why?
|
| Ataxia | 1 | 2018 | 304 | 0.040 |
Why?
|
| Aging | 1 | 2015 | 8626 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2020 | 2837 | 0.030 |
Why?
|
| Vancomycin | 1 | 2019 | 500 | 0.030 |
Why?
|
| Middle Aged | 5 | 2021 | 213127 | 0.030 |
Why?
|
| Bacteroides | 1 | 2016 | 161 | 0.030 |
Why?
|
| Breath Tests | 1 | 2016 | 276 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 6171 | 0.030 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 10163 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 814 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2019 | 754 | 0.030 |
Why?
|
| Malaysia | 1 | 2014 | 92 | 0.030 |
Why?
|
| Helminths | 1 | 2014 | 35 | 0.030 |
Why?
|
| Fibrosis | 1 | 2021 | 2026 | 0.030 |
Why?
|
| India | 1 | 2020 | 2187 | 0.030 |
Why?
|
| Cytokines | 2 | 2021 | 7317 | 0.030 |
Why?
|
| Lectins | 1 | 2016 | 514 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 527 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2017 | 8297 | 0.030 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2012 | 59 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 2017 | 637 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2016 | 1078 | 0.030 |
Why?
|
| Weaning | 1 | 2012 | 105 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2016 | 544 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2016 | 540 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2017 | 1200 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 544 | 0.030 |
Why?
|
| New York City | 1 | 2014 | 706 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2012 | 101 | 0.030 |
Why?
|
| Cecum | 1 | 2012 | 237 | 0.030 |
Why?
|
| Metagenomics | 1 | 2015 | 430 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 3913 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2016 | 1866 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2019 | 2014 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 1835 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2012 | 561 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 9410 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2016 | 1538 | 0.020 |
Why?
|
| Genetic Fitness | 1 | 2012 | 121 | 0.020 |
Why?
|
| Metabolomics | 1 | 2019 | 1467 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2020 | 21719 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 13921 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2017 | 1426 | 0.020 |
Why?
|
| Infant | 3 | 2017 | 35070 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2016 | 1469 | 0.020 |
Why?
|
| Phenotype | 2 | 2017 | 16331 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2017 | 40955 | 0.020 |
Why?
|
| Bone Development | 1 | 2012 | 483 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 9735 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 2016 | 904 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2012 | 509 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2018 | 5975 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 4929 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1889 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14554 | 0.020 |
Why?
|
| Proteomics | 1 | 2019 | 3618 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 2986 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2012 | 1170 | 0.020 |
Why?
|
| Young Adult | 3 | 2018 | 56350 | 0.020 |
Why?
|
| Internet | 1 | 2017 | 3062 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3585 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 6483 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 15994 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11363 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 6540 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 4554 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 1887 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2016 | 2956 | 0.010 |
Why?
|
| Child | 3 | 2017 | 77478 | 0.010 |
Why?
|
| Adolescent | 3 | 2017 | 85649 | 0.010 |
Why?
|
| Cholesterol | 1 | 2012 | 2895 | 0.010 |
Why?
|
| Body Composition | 1 | 2012 | 2400 | 0.010 |
Why?
|
| Macrophages | 1 | 2016 | 5655 | 0.010 |
Why?
|
| Prevalence | 1 | 2017 | 15194 | 0.010 |
Why?
|
| Bone Density | 1 | 2012 | 3469 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 25575 | 0.010 |
Why?
|
| Age Factors | 1 | 2012 | 18355 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 53187 | 0.010 |
Why?
|
| Mutation | 1 | 2012 | 29717 | 0.000 |
Why?
|
Concepts
(212)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_